Tellurian Shareholder Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tellurian To Contact Him Directly To Discuss Their Options

New York, New York–(Newsfile Corp. – January 30, 2022) – Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tellurian, Inc. (“Tellurian” or the “Company”) (NYSE American: TELL).

If you suffered losses exceeding $50,000 investing in Tellurian stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/TELL.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6455/112087_418840dfa4133918_001.jpg

There is no cost or obligation to you.

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.

On January 20, 2022, Tellurian’s Chief Executive Officer (“CEO”), Charif Souki, was sued by Christopher Parker, who invested tens of millions of dollars in the Company. When Parker sought to sell his shares in mid-2019, Souki allegedly induced him to delay selling Tellurian shares by offering to indemnify Parker against any losses through the end of 2020. This agreement was memorialized by text messages. When Parker sought a written agreement extending the term to December 31, 2021 and providing for interest, Souki allegedly agreed to the terms but refused to sign the agreement because Souki omitted the liability in his disclosures to his lenders.

On this news, Tellurians’ stock price fell $0.17, or 6%, to close at $2.65 per share on January 21, 2022.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/112087